| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, December 2006, p. 7014-7020, Vol. 74, No. 12
0019-9567/06/$08.00+0 doi:10.1128/IAI.02063-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
,
Departments of Bacteriology,1 Periodontal Medicine, Hiroshima University Graduate School of Biomedical Sciences, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8553, Japan,2 Department of Mathematical and Life Sciences, Hiroshima University Graduate School of Science, Higashi-Hiroshima 739-8526, Japan3
Received 22 December 2005/ Returned for modification 24 April 2006/ Accepted 12 September 2006
Clinical Actinobacillus actinomycetemcomitans produces cytolethal distending toxin (CDT) with titers ranging from 102 to 108 U/mg. Single nucleotide polymorphism analysis of the cdt gene in clinical isolates identified a variation of a single amino acid at residue 281 of CdtB, which significantly affected CDT toxicity by modulating the chromatin-degrading activity of CdtB.
Published ahead of print on 18 September 2006.
Supplemental material for this article may be found at http://iai.asm.org/.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|